{
    "title": "U.S. top court hears Teva's multiple sclerosis drug patent fight",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2793514/U-S-court-hears-Tevas-multiple-sclerosis-drug-patent-fight.html",
    "date": "2014-10-15",
    "keywords": [
        "court",
        "patent",
        "drug",
        "teva",
        "case",
        "copaxone",
        "inc",
        "sclerosis",
        "fight",
        "october",
        "gmt",
        "lawrence",
        "momenta",
        "mylan",
        "circuit",
        "end",
        "term",
        "email",
        "hurleywashington",
        "wednesday",
        "business",
        "argument",
        "possibleteva",
        "percent",
        "novartis",
        "pharma",
        "stake",
        "september",
        "july",
        "appeal",
        "fate",
        "government",
        "approval",
        "sandoz",
        "product",
        "meantime",
        "formulation",
        "copaxonethe",
        "tevas",
        "version",
        "year",
        "analyst",
        "raffat",
        "investment",
        "research",
        "firm",
        "proportion",
        "property",
        "history",
        "week",
        "lot",
        "system",
        "professor",
        "university",
        "california",
        "school",
        "law",
        "supreme",
        "interest",
        "termthe",
        "world",
        "district",
        "judgesa",
        "ruling",
        "june",
        "reporting",
        "hurley"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}